Romi Bhasin, MD, PhD, FACE

Columbus Endocrinology, Columbus Endocrinology Gahanna

Provider Overview

Provider Background

Areas of Interest

  • Endocrinology

Associations & Organizations

  • Member, Alpha Omega Alpha honor society (AOA)
  • Elected member, Association of Pathology Chairs Honor Society
  • Research Award, Asians in Medicine (AIM), S.U.N.Y.

Publications

  • Bhasin, R., Arce, F.C. and Pasmantier, R. “ Hypoglycemia associated with Use of gatifloxacin” Amer. J. Med. Sci. 330/5, 250-253 (2005).
  • Arce, F.C., Bhasin, R., and Pasmantier, R. “ Severe Hyperglycemia in Non-diabetic patients receiving Gatifloxacin.” Endocrine Practice 10(1), 40-44 (2004).
  • Bhasin, R., Gregori, L., Morozov, I., and Goldgaber, D. “ A Processing Pathway for Amyloid Beta Protein Precursor Generates a Secreted Form With an Intact Carboxyl Terminus.” Amyloid: J.exp. Clin. Invest. 1, 221-231 (1994).
  • Gregori, L., Bhasin, R., and Goldgaber, D. “ Ubiquitin-mediated degradation pathway degrades the extracellular but not the intracellular form of amyloid beta protein precursor. Biochem. Biophys. Res. Commun. 203 (3), 1731-1738, (1994).
  • Schwarzman, A.L., Gregori, L., Vitek, M.P., Lyubski, S., Stritmatter, W.J., Enghilde, J.J., Bhasin, R., Silverman, J., Weigraber, K.H., Coyle, P.K., et. al. “Transthyretin sequesters amyloid beta protein precursor and prevents amyloid formation.” Proc. Natl. Acad. Sci. (USA) 91 (18), 8368-8372.
  • Goldgaber, D., Schwarzman, A.L., Bhasin, R., Gregori, L., Schemchel, D., Saunders, A.M., Roses, A.D., and Stritmatter, W.J. “Sequestration of amyloid beta peptide.” Annals of the New York Academy of Sciences, 695, 139-143, (1993).
  • Stritmatter, W.J., Huang, D.Y., Bhasin, R., Roses, A.D. and Goldgaber, D. “Avid binding of beta amyloid to it’s own precursor.” Exp. Neurol. 122(2), 327-334, (1993).

Previous Organizations & Titles

  • Private Practice in Endocrinology
  • Contract Physician, VA
  • Contract Physician, Emergency Room, VA

Medical School

Renaissance School of Medicine at Stony Brook University

Board Certification

American Board of Internal Medicine Endocrinology & Metabolism American Board of Internal Medicine

Insurances Accepted

Aetna

Aetna Better Health aka Aetna MyCare

Aetna Medicare (COPC Senior Care Advantage Participant)

Anthem Blue Cross Blue Shield

BCMH

Caresource Marketplace

Cigna

First Health

HealthSmart

Humana Commercial

Humana Medicare (COPC Senior Care Advantage Participant)

Medicaid

Medical Mutual of Ohio (MMO)

Medical Mutual OhioHealth HMO

Medicare

MediGold (COPC Senior Care Advantage Participant)

Meritain

Molina Medicaid - Established Patients Only

Mt.Carmel Health Partners Trinity Health Plan

Multiplan

Ohio Health Choice (OHCP)

OhioHealthy

OSCAR Buckeye Health

OSU Health Plans

PHCS

PPO Connect

Railroad Medicare

Tricare Prime Remote-PCP/SCP Network Plan

Tricare Standard

Trinity Health Plan - Aetna Administered

UMWA

UnitedHealthcare

Central Ohio Primary Care Logo

Romi Bhasin, MD, PhD, FACE

Columbus Endocrinology


Gender

Male

Specialties

Endocrinology, Internal Medicine

Medical School

Renaissance School of Medicine at Stony Brook University

Board Certification

American Board of Internal Medicine Endocrinology & Metabolism American Board of Internal Medicine

Languages Spoken

Hindi, English

Accepting New Patients

Yes

Associations & Organizations
  • Member, Alpha Omega Alpha honor society (AOA)
  • Elected member, Association of Pathology Chairs Honor Society
  • Research Award, Asians in Medicine (AIM), S.U.N.Y.


Publications
  • Bhasin, R., Arce, F.C. and Pasmantier, R. “ Hypoglycemia associated with Use of gatifloxacin” Amer. J. Med. Sci. 330/5, 250-253 (2005).
  • Arce, F.C., Bhasin, R., and Pasmantier, R. “ Severe Hyperglycemia in Non-diabetic patients receiving Gatifloxacin.” Endocrine Practice 10(1), 40-44 (2004).
  • Bhasin, R., Gregori, L., Morozov, I., and Goldgaber, D. “ A Processing Pathway for Amyloid Beta Protein Precursor Generates a Secreted Form With an Intact Carboxyl Terminus.” Amyloid: J.exp. Clin. Invest. 1, 221-231 (1994).
  • Gregori, L., Bhasin, R., and Goldgaber, D. “ Ubiquitin-mediated degradation pathway degrades the extracellular but not the intracellular form of amyloid beta protein precursor. Biochem. Biophys. Res. Commun. 203 (3), 1731-1738, (1994).
  • Schwarzman, A.L., Gregori, L., Vitek, M.P., Lyubski, S., Stritmatter, W.J., Enghilde, J.J., Bhasin, R., Silverman, J., Weigraber, K.H., Coyle, P.K., et. al. “Transthyretin sequesters amyloid beta protein precursor and prevents amyloid formation.” Proc. Natl. Acad. Sci. (USA) 91 (18), 8368-8372.
  • Goldgaber, D., Schwarzman, A.L., Bhasin, R., Gregori, L., Schemchel, D., Saunders, A.M., Roses, A.D., and Stritmatter, W.J. “Sequestration of amyloid beta peptide.” Annals of the New York Academy of Sciences, 695, 139-143, (1993).
  • Stritmatter, W.J., Huang, D.Y., Bhasin, R., Roses, A.D. and Goldgaber, D. “Avid binding of beta amyloid to it’s own precursor.” Exp. Neurol. 122(2), 327-334, (1993).


Previous Organizations & Titles
  • Private Practice in Endocrinology
  • Contract Physician, VA
  • Contract Physician, Emergency Room, VA